No Detail Found!

Factors Influencing the Response of Interferon Therapy in Chronic Hepatitis C Patients

Author(s)
Waquar Uddin Ahmed PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Ambreen Arif PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Huma Qureshi Pakistan Medical Research Council, Islamabad, Pakistan
Syed Ejaz Alam PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Raheel Ather PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Shamoona Fariha PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Javeria Waquar PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Abstract
Objective: To determine factors influencing response of interferon therapy in chronic hepatitis C patients. Study Design: Descriptive, analytical study. Place and Duration of Study: Pakistan Medical Research Centre, Jinnah Postgraduate Medical Centre, Karachi, from January 1998 to December 2009. Methodology: Patients of chronic hepatitis C treated with conventional interferon were retrospectively analyzed. End treatment response at 6 months for genotype 2 and 3 and one-year for genotype 1 and 4 was assessed. Sustained virological response was checked after 6 months of cessation of therapy. Non-compliant and incomplete follow-up cases were excluded. Factors influencing the response to therapy were analyzed by univariate and multivariate logistic regression analysis. Results: A total of 932 cases received interferon therapy; 103 were lost to follow-up and were excluded. Treatment was completed in 829 cases; end treatment response was 74% (615 out of 829 cases). Six months post-treatment follow-up was available in 492 cases. Sustained virological response was seen in 63% (308 out of 492 cases). Univariate logisticregression analysis showed significantly better response in patients with < 40 years of age, body weight < 70 kg, normal platelet count, serum albumin > 4.0 grams, non diabetic patients and those with a normal alanine aminotransferase (ALT) at 1st month of therapy. Multiple logistic regression analysis showed that only age < 40 years was significantly important for sustained virological response. Conclusion: For conventional interferon therapy, age < 40 years is the best predictor for sustained virological response, however, better response can be achieved in patients with < 70 kg weight, normal platelet count, serum albumin > 4.0 grams, non-diabetics and patients having normal ALT at 1st month of therapy.
Publication Details
Page(s) 69-73
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 21, Issue: 2, Year: 2011

Request the full text from PASTIC

0

Citations

0

Downloads

58

Views